sur Onco-Innovations Limited (CVE:ONCO)
Onco-Innovations to List Shares on Cboe Canada
Onco-Innovations Limited has announced the transfer of its common shares listing to Cboe Canada from the Canadian Securities Exchange (CSE). Trading is set to commence on May 22, 2025, under the ticker "ONCO." The voluntary delisting from the CSE is expected at the close on May 21, 2025. Shareholders need not take action during this transition.
Cboe Canada provides a reputable platform as part of the Cboe Markets network. It supports companies with notable market infrastructure and data solutions. This strategic move aligns with Onco-Innovations' goals of visibility and investor engagement in the oncology sector.
CEO Thomas O'Shaughnessy stated that this step will enhance engagement and broaden the investor base, aligning financial strategies with scientific goals.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Onco-Innovations Limited